Brief: Hlb Inc To Acquire 16 Billion Won Worth Of Shares In Neurotobe Pharmaceuticals Inc
10/09/2024 08:18
HLB Inc 028300.KQ :
* HLB INC: TO ACQUIRE 16 BILLION WON WORTH OF SHARES IN
NEUROTOBE
PHARMACEUTICALS INC
Source text for Eikon: ID:
Further company coverage: 028300.KQ
Recent news on HLB
See all newsBrief: Hlb Co Resubmits New Drug Application Of Rivoceranib To Us FDA
Elevar-Hengrui hit with third FDA rejection for liver cancer therapy over manufacturing concerns (updated)
Brief: Elevar Therapeutics' NDA Resubmission For Rivoceranib With Camrelizumab Accepted By FDA
Brief: Elevar Therapeutics Resubmits NDA To U.S. FDA For Camrelizumab Plus Rivoceranib Astreatment For Unresectable Hepatocellular Carcinoma
Brief: Hlb Inc To Acquire 16 Billion Won Worth Of Shares In Neurotobe Pharmaceuticals Inc